Bausch + Lomb Receives US FDA Clearance for Biotrue™ ONEday Contact Lenses
Made From Breakthrough HyperGel™ Material, Daily Disposable Lens Provides Exceptional Vision and Comfort. Even After 16 Hours of Wear.
CHICAGO, June 28, 2012 /PRNewswire/ -- Today at the American Optometric Association (AOA) annual conference, Bausch + Lomb, the global eye health company, announced that the U.S. Food and Drug Administration has issued clearance of Biotrue™ ONEday, a premium daily disposable contact lens. Biotrue ONEday is made from HyperGel™, an innovative, next generation of daily disposable material that has the best features of conventional hydrogels and silicone hydrogels. The lens offers high water content and delivers more oxygen than a traditional hydrogel – all without the need for silicone – while maintaining the comfort of conventional hydrogels. Biotrue ONEday contact lenses provide consistent, clear, comfortable vision throughout the day because the innovative, bio-inspired material helps them retain moisture and optical shape even after hours of wear. As a bio-inspired product, these lenses extend the Biotrue brand portfolio which also includes Biotrue® multi-purpose solution.
Biotrue ONEday was created by the eye health scientists at Bausch + Lomb to be the first daily disposable lens with three bio-inspired features. The bio-inspired lenses contain 78 percent water, the same water content as the cornea, and deliver the oxygen level needed by the open eye to maintain healthy, white eyes. The outer surface of the lens is designed to mimic the lipid layer of tear film to prevent dehydration. Biotrue ONEday lenses provide the maximum amount of moisture of any daily disposable lens on the market today, even after 16 hours of wear.
"Patients often report that they have blurred vision at the end of the day or have to blink a few times to clear their vision when they are working on their computer. Blurred vision can be caused by contact lenses losing moisture, which changes the shape of the contact lens and can distort their clarity of vision," said Calvin Roberts M.D., executive vice president and chief medical officer, Bausch + Lomb. "HyperGel helps our new Biotrue ONEday contact lenses mimic our own healthy tears and maintains virtually the same moisture level of the natural eye. This helps Biotrue ONEday contact lenses retain their shape and maintain clear vision throughout the day."
"Bausch + Lomb is deeply committed to continued innovation in contact lenses and solutions, and today's introduction of Biotrue ONEday lenses represents another important step in the company's mission of helping people see better to live better," said Sheila Hopkins, president, global Vision Care, Bausch + Lomb. "Biotrue ONEday lenses are the first contact lenses to feature the revolutionary new material HyperGel offering contact lens wearers comfortable vision throughout the day and helping to address the unmet needs of today's contact lens wearer."
Biotrue ONEday lenses were introduced in May in Italy and will be introduced in the U.K. and Nordics later in the year.
About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, NY, and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
All other product/brand names are trademarks of their respective owners.
®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates.
© 2012 Bausch & Lomb Incorporated.
SOURCE Bausch + LombBack to top